BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,617,346 | -15.2% | 72,030 | +6.7% | 0.00% | 0.0% |
| Q2 2023 | $4,267,833 | +30.4% | 67,529 | -7.2% | 0.00% | 0.0% |
| Q1 2023 | $3,273,292 | +7.6% | 72,756 | +4.7% | 0.00% | 0.0% |
| Q4 2022 | $3,043,261 | -30.2% | 69,465 | +5.0% | 0.00% | 0.0% |
| Q3 2022 | $4,357,000 | -49.7% | 66,139 | -61.4% | 0.00% | -66.7% |
| Q2 2022 | $8,663,000 | +78.7% | 171,505 | +126.1% | 0.00% | +200.0% |
| Q1 2022 | $4,847,000 | -53.4% | 75,858 | -21.9% | 0.00% | -66.7% |
| Q4 2021 | $10,400,000 | -28.9% | 97,101 | -31.7% | 0.00% | -25.0% |
| Q3 2021 | $14,623,000 | +3.7% | 142,227 | -11.3% | 0.00% | +33.3% |
| Q2 2021 | $14,101,000 | -89.4% | 160,332 | -88.2% | 0.00% | -91.4% |
| Q1 2021 | $132,499,000 | -12.5% | 1,362,734 | +0.9% | 0.04% | -20.5% |
| Q4 2020 | $151,432,000 | +30.6% | 1,350,271 | +8.0% | 0.04% | +12.8% |
| Q3 2020 | $115,922,000 | +18.6% | 1,250,516 | -0.2% | 0.04% | +11.4% |
| Q2 2020 | $97,765,000 | +33.3% | 1,253,397 | -0.0% | 0.04% | +12.9% |
| Q1 2020 | $73,333,000 | -40.5% | 1,253,992 | -18.5% | 0.03% | -18.4% |
| Q4 2019 | $123,196,000 | +10.3% | 1,537,831 | +1.2% | 0.04% | +31.0% |
| Q3 2019 | $111,655,000 | -34.3% | 1,519,735 | -15.6% | 0.03% | -34.1% |
| Q2 2019 | $169,897,000 | +22613.5% | 1,801,102 | +19169.3% | 0.04% | – |
| Q1 2019 | $748,000 | +201.6% | 9,347 | +194.1% | 0.00% | – |
| Q3 2018 | $248,000 | -95.7% | 3,178 | -96.5% | 0.00% | -100.0% |
| Q2 2018 | $5,761,000 | +199.0% | 90,746 | +331.9% | 0.00% | +100.0% |
| Q1 2018 | $1,927,000 | -58.1% | 21,009 | -65.6% | 0.00% | -50.0% |
| Q4 2017 | $4,604,000 | -9.2% | 61,058 | -16.1% | 0.00% | 0.0% |
| Q3 2017 | $5,070,000 | +114.4% | 72,774 | +55.9% | 0.00% | +100.0% |
| Q2 2017 | $2,365,000 | +361.0% | 46,665 | +155.0% | 0.00% | – |
| Q4 2016 | $513,000 | +10160.0% | 18,298 | +10237.9% | 0.00% | – |
| Q2 2015 | $5,000 | – | 177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |